Clinical Trials Directory

Trials / Completed

CompletedNCT04005612

Effect of Vitamin d and Omega 3 on Osteocalcin

Assessing the Combined Effect of Omega-3 Fatty Acid and Vitamin D3 on Plasma Osteocalcin Levels : a Randomized Controlled Trial in Males and Females With Vitamin D Deficiency

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Applied Science Private University · Academic / Other
Sex
All
Age
22 Years – 50 Years
Healthy volunteers
Accepted

Summary

Assessing the combined effect of omega-3 fatty acid and vitamin D 3 on plasma osteocalcin levels

Detailed description

The data about effect of vitamin D3 (VD3) and omega-3 fatty acids(omega-3FA) on plasma levels of osteocalcin (OCN) are scarce and conflicting and nothing is published in the literature about the effect of the combination of VD3 and omega-3FA on the OCN levels. This study was conducted to investigate effect of VD3 and omega-3FA alone and with each other on PLASMA OCN levels in females and males with vitamin D deficiency (VDD). This randomized, controlled clinical trial was designed to test effects of 50,000 IU VD3 weekly and 300 mg omega-3FA daily for eight weeks,separately and with each other, on the plasma levels of OCN and 25-hydroxy vitamin D (25OHD). This study was conducted during winter in 86 healthy Jordanian females and males with VDD with a mean age of (40± 10) years. Fasting serum levels for 25OHD,OCN, PTH (parathyroid hormone),calcium, phosphate, ALT (alanine aminotransferase), and urea were assessed at baseline and the end of the trial .

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTvitamin D350,000 IU VD3 / week for 8 weeks
DIETARY_SUPPLEMENTomega-3 fatty acid300 mg of omega 3-FA once daily for 8 weeks
DIETARY_SUPPLEMENTvitamin D3 and omega-3 fatty acid50,000 IU VD3 / week for 8 weeks and 300 mg of omega-3FA once daily for 8 weeks
OTHERcontrolno intervention

Timeline

Start date
2019-11-01
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2019-07-02
Last updated
2020-07-14

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT04005612. Inclusion in this directory is not an endorsement.